|
|
 |
|
Viewing report
|
|
 |
 |
Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and New Developments
Datamonitor, Sep 2001
Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and New Developments, provides comprehensive insight into future changes in the ovarian cancer market, with an overview of the disease and current treatments, followed by in-depth analysis of the ovarian cancer pipeline by development strategy, drug class, region and company type, and concluding with forecasts of the likely impact these new drugs will have on the future market.
Customers who bought this item also bought
Cancer Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Current Therapies for Ovarian Cancer
The Cancer Outlook to 2007
Drugs of Tomorrow 2001: Cancer Overview
New Cancer Therapeutics: An Analysis Of Current And Emerging Markets
Stakeholder Opinions: Ovarian Cancer - Beyond Carboplatin and Paclitaxel
Cancer Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
|
 |
|
|